Preclinical Evaluation of a New Anti-COVID-19 Intravenous Immunoglobulin

Preclinical Evaluation of a New Anti-COVID-19 Intravenous Immunoglobulin

Introduction. Using of immunoglobulins containing SARS-CoV-2 neutralizing antibodies may be an effective and safe tool for COVID-19 treatment. An intravenous immunoglobulin COVID-globulin from donor blood plasma containing SARS-CoV-2 neutralizing antibodies was developed at Joint-Stock Company Nacim...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. M. Nikolaeva, A. V. Ivanov, T. I. Smolyanova, M. V. Razumikhin, O. V. Belyakova, E. G. Shilova, N. R. Selezneva, T. V. Vyaznikova, A. I. Semicheva, E. I. Sakanyan
Format:	Article
Language:	Russian
Published:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2023-02-01
Series:	Разработка и регистрация лекарственных средств
Subjects:	intravenous immunoglobulin preclinical studies toxicity safety coronavirus infection covid-19
Online Access:	https://www.pharmjournal.ru/jour/article/view/1446
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

INTRAVENOUS IMMUNOGLOBULIN IN PEDIATRIC RHEUMATOLOGY PRACTICE
by: E. I. Alexeeva, et al.
Published: (2015-04-01)

The place of intravenous immunoglobulin in rheumatic diseases
by: N. V. Seredavkina, et al.
Published: (2016-01-01)

Determination of optimum nanofiltration conditions for the manufacturing process of human normal immunoglobulin G for intravenous administration
by: N. V. Zubkova, et al.
Published: (2023-10-01)

USE OF INTRAVENOUS IMMUNOGLOBULIN WITHIN THE IVF/ICSI PROTOCOL IN WOMEN WITH INFERTILITY AND ANTIPHOSPHOLIPID ANTIBODIES
by: M. I. Krivonos, et al.
Published: (2017-12-01)

INTRAVENOUS IMMUNOGLOBULIN APPLICATION IN CLINICAL PRACTICE
by: T. V. Latysheva, et al.
Published: (2013-01-01)

EXPERIENCE OF INTRAVENOUS INJECTION OF NORMAL HUMAN IMMUNOGLOBULIN IN A PATIENT WITH KAWASAKI SYNDROME
by: T. V. Sleptsova, et al.
Published: (2014-07-01)

Peculiar features of intravenous immunoglobulins application in rheumatic diseases
by: O. N. Egorova, et al.
Published: (2024-06-01)

Does the Use of Intravenous Immunoglobulin Improve Clinical Outcomes in Adults With Autoimmune Encephalitis? A Systematic Review
by: Anahat Kalra, et al.
Published: (2025-05-01)

Use of plasmapheresis and intravenous immunoglobulins in pregnant women with antiphospholipid syndrome
by: E. S. Orlova, et al.
Published: (2025-01-01)

High Efficiency of Human Normal Immunoglobulin for Intravenous Administration in a Patient with Kawasaki Syndrome Diagnosed in the Later Stages
by: Tatyana V. Sleptsova, et al.
Published: (2016-09-01)

Effects of intravenous immunoglobulin on the negatively transformed subpopulations of neutrophilic granulocytes in newborns with congenital pneumonia and neonatal sepsis
by: I. V. Nesterova, et al.
Published: (2024-01-01)

METHODOLOGICAL APPROACHES TO EXPERT EVALUATION OF PRECLINICAL AND CLINICAL TRIALS OF HUMAN IMMUNOGLOBULIN PRODUCTS
by: V. B. Ivanov, et al.
Published: (2017-10-01)

Intravenous Immunoglobulin-Induced Dyspnea and Bradycardia in a Patient with Guillain–Barre Syndrome
by: Harleen Kaur, et al.
Published: (2024-10-01)

Phase I Pharmacokinetics Study of Drug «COVID-globulin» (Specific Human Immunoglobulin Against COVID-19)
by: T. I. Smolyanova, et al.
Published: (2022-05-01)

Use of intravenous immunoglobulin in neonates with haemolytic disease and immune thrombocytopenia
by: Marković-Sovtić Gordana, et al.
Published: (2013-01-01)

INTRAVENOUS IMMUNOGLOBULIN ADMINISTRATION FOR DESENSITIZATION BEFORE RENAL TRANSPLANTATION AND MANAGING ANTIBODY-MEDIATED REJECTION
by: A. I. Sushkov, et al.
Published: (2011-06-01)

Intravenous immunoglobulin for intensive therapy of fibrosing alveolitis in a patient TOC \o "1-5" \h \z with systemic sclerosis
by: R T Alekperov, et al.
Published: (2004-02-01)

Effect of additional intravenous immunoglobulin for infliximab-refractory Kawasaki disease: a cohort study
by: Satoki Hatano, et al.
Published: (2025-05-01)

Chronic Severe Neutropenia Associated With Intravenous Immunoglobulin for Multifocal Motor Neuropathy
by: Shannon Ugarte, et al.
Published: (2025-02-01)

Efficacy of Intravenous Immunoglobulins and Other Immunotherapies in Neurological Disorders and Immunological Mechanisms Involved
by: Angel Justiz-Vaillant, et al.
Published: (2025-05-01)

Intravenous immunoglobulin for mortality and inflammatory status in patients with sepsis: a retrospective database study
by: Hayabusa Takano, et al.
Published: (2025-01-01)

Comparison of the Efficacy of Intravenous Immunoglobulin with Methylprednisolone as First-line Therapy in Multisystem Inflammatory Syndrome in Children: A Prospective Cohort Study
by: Navya S Manugu, et al.
Published: (2025-06-01)

Intravenous immunoglobulin: prospects in patients with autoimmune rheumatic diseases
by: Elena Aleksandrovna Aseeva, et al.
Published: (2014-03-01)

Therapeutic efficacy of intravenous immunoglobulin in ulcerative colitis
by: LONG Qian, et al.
Published: (2025-04-01)

Hashimoto's encephalopathy: A long-lasting remission induced by intravenous immunoglobulins
by: Drulović Jelena, et al.
Published: (2011-01-01)

Treatment with intravenous immunoglobulin modulates coagulation- and complement-related pathways in COVID-19 patients
by: Dominic McGrosso, et al.
Published: (2025-07-01)

Establishment and validation of risk prediction model to predict intravenous immunoglobulin-resistance in Kawasaki disease based on meta-analysis of 15 cohorts
by: Shuhui Wang, et al.
Published: (2025-02-01)

Impact of intravenous immunoglobulin treatment on peripheral blood cells in children with Kawasaki disease complicated with coronary artery lesion
by: Junshan Zhao, et al.
Published: (2025-02-01)

Interpretable web-based machine learning model for predicting intravenous immunoglobulin resistance in Kawasaki disease
by: Ying He, et al.
Published: (2025-06-01)

An autochthonous case of severe tick-borne encephalitis virus associated meningoencephalitis in France: Is there a place for polyvalent intravenous immunoglobulins?
by: Paul Dalmas, et al.
Published: (2025-01-01)

The efficacy and safety of intravenous immunoglobulin infusion in 12 h for the initial treatment of Kawasaki disease
by: Satoshi Asano, et al.
Published: (2024-09-01)

Plasma exchange alone versus combination with intravenous immunoglobulin/methylprednisolone pulse therapy in severe systemic rheumatic diseases: a retrospective study
by: Jing Guo, et al.
Published: (2024-12-01)

The effects of glucocorticoid plus intravenous immunoglobulin (IVIG) vs IVIG alone on platelet activation in children with Kawasaki disease
by: Qiong-Qiong Wang, et al.
Published: (2023-08-01)

Diagnosis of hereditary transthyretin amyloidosis in patients with suspected chronic inflammatory demyelinating polyneuropathy unresponsive to intravenous immunoglobulins: results of a retrospective study
by: Yann Péréon, et al.
Published: (2025-03-01)

Intravenous immunoglobulin therapy: usage patterns and response to treatment in Qatar over ten years
by: Salma A. Taha, et al.
Published: (2024-12-01)

The effect of subcutaneous immunoglobulin replacement therapy on serum IgG levels in patients with primary immunodeficiency
by: Selime Özen Bölük, et al.
Published: (2023-06-01)

Advantage of the subcutaneous immunoglobulin replacement therapy in primary immunodeficient patients with or without secondary protein loss
by: Pınar Gür-Çetinkaya, et al.
Published: (2018-06-01)

A visualized nomogram to predict intravenous immunoglobulin resistance in Kawasaki disease: a study based on the population in Southern China
by: Xinping Lin, et al.
Published: (2025-04-01)

Рrospective multicenter study of treatment efficacy, safety, and quality of life in a large cohort of patients with inborn errors of immunity receiving subcutaneous immunoglobulin by the rapid push method
by: Asmik Avedova, et al.
Published: (2025-07-01)

Intravenous immunoglobulin therapy in erythromelalgia management: a case report
by: Renato Ádler Pomilio de Sousa, et al.
Published: (2025-03-01)